Our analysis indicates that the mortality burden associated with AMI and acute myocarditis was significantly lower among individuals with COVID-19 compared to those with influenza in the U.S. between 2020 and 2024. This discrepancy may reflect important differences in study design, including data sources, population characteristics, and endpoint definitions—specifically, clinical incidence versus death certificate-based mortality. Nonetheless, our findings underscore the substantial acute cardiovascular risk posed by influenza and reinforce the importance of not underestimating its potential to cause acute myocardial damage.
Mortality Risk of Acute Myocardial Infarction and Acute Myocarditis in COVID-19 and Influenza: A U.S. Nationwide Analysis Using Death Certificates
Mattiuzzi, Camilla;Lippi, Giuseppe
2025-01-01
Abstract
Our analysis indicates that the mortality burden associated with AMI and acute myocarditis was significantly lower among individuals with COVID-19 compared to those with influenza in the U.S. between 2020 and 2024. This discrepancy may reflect important differences in study design, including data sources, population characteristics, and endpoint definitions—specifically, clinical incidence versus death certificate-based mortality. Nonetheless, our findings underscore the substantial acute cardiovascular risk posed by influenza and reinforce the importance of not underestimating its potential to cause acute myocardial damage.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
